Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1972 Apr 1;2(5804):21-4.
doi: 10.1136/bmj.2.5804.21.

Outpatient treatment trial of mild and severe hypertension

Clinical Trial

Outpatient treatment trial of mild and severe hypertension

K L Stuart et al. Br Med J. .

Abstract

Not much is known about the feasibility or the advantages of treatment of subjects with only mild hypertension. There are also many unresolved problems in the outpatient management of hypertension of any severity. In this study an analysis is made of the results of a controlled treatment trial of 56 subjects with mild hypertension, 26 of whom were treated with active drug and 30 initially with placebo, and a treatment programme involving 81 patients with moderate or severe hypertension, all of whom received treatment with active drug. The drugs used in this study were bethanidine, debrisoquine, and guanethidine.Follow-up for 12 months or more was achieved in 87% of individuals admitted to the study with mild hypertension and in 80% with severe hypertension. Many subjects with only mildly raised blood pressure were found to have cardiac enlargement on chest x-ray (up to 45%) and left ventricular hypertrophy on electrocardiogram (up to 51%). Rapid rates of rise of blood pressure were observed in many placebo-treated subjects; but good blood pressure control was achieved in 63 out of 104 patients (61%) receiving active drug in both the mild and the severe hypertension groups. The drugs used showed approximately equal effectiveness in controlling blood pressure.

PubMed Disclaimer

References

    1. Lancet. 1964 Sep 26;2(7361):659-61 - PubMed
    1. Br Med Bull. 1971 Jan;27(1):37-42 - PubMed
    1. Br Med J. 1967 Dec 2;4(5578):519-21 - PubMed
    1. Br Med J. 1962 Aug 25;2(5303):497-506 - PubMed
    1. Br Med J. 1967 Jun 10;2(5553):660-4 - PubMed

Publication types

LinkOut - more resources